Fuller & Thaler Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

Fuller & Thaler Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-155,035	Closed	-$9.71M	–	483
2019 Q1	$9.71M	Buy	155,035 +5,902	+4%	+$405K	0.12%	146
2018 Q4	$8.91M	Sell	149,133 -5,204	-3%	-$312K	0.13%	139
2018 Q3	$9.95M	Buy	+154,337	New	+$8.61M	0.1%	156
2015 Q3	–	Sell	-224	Closed	-$2K	–	826
2015 Q2	$2K	Buy	+224	New	+$2.07K	﹤0.01%	660
2014 Q3	–	Sell	-362,850	Closed	-$2.6M	–	769
2014 Q2	$2.6M	Sell	362,850 -49,900	-12%	-$397K	0.11%	183
2014 Q1	$4.17M	Sell	412,750 -48,400	-10%	-$445K	0.2%	153
2013 Q4	$3.66M	Sell	461,150 -11,750	-2%	-$110K	0.2%	162
2013 Q3	$4.69M	Buy	+472,900	New	+$3.72M	0.28%	140

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fuller & Thaler Asset Management's BEAT Position: Q2 2019 in Review

Fuller & Thaler Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q2 2019, closing a stake of 155,035 shares — an estimated $9.71M sold.

Fuller & Thaler Asset Management first reported a position in BEAT in Q3 2013 and held it in 8 quarters. The position peaked at $9.95M in Q3 2018. 251 funds tracked by Wall St. Rank hold BEAT as of Q2 2019.

Fuller & Thaler Asset Management reported no remaining BioTelemetry, Inc. position as of Q2 2019 after selling out during the quarter.
Fuller & Thaler Asset Management sold 155,035 BioTelemetry, Inc. shares in Q2 2019, an estimated $9.71M.
Fuller & Thaler Asset Management first reported a position in BioTelemetry, Inc. in Q3 2013 and held it in 8 quarters.
Fuller & Thaler Asset Management's BioTelemetry, Inc. position peaked at $9.95M in Q3 2018.
251 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2019.

Based on Fuller & Thaler Asset Management's 13F filing for Q2 2019, filed 13 Aug 2019.